BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study

被引：29

作者：

Frank, Bernd ^{[1
]}

Hemminki, Kari

Meindl, Alfons

Wappenschmidt, Barbara

Sutter, Christian

Kiechle, Marion

Bugert, Peter

Schmutzler, Rita K.

Bartram, Claus R.

Burwinkel, Barbara

机构：

[1] DKFZ, Helmholtz Univ Grp Mol Epidemiol, German Canc Res Ctr, Heidelberg, Germany

[2] DKFZ, Div Mol Genet Epidemiol, German Canc Res Ctr, Heidelberg, Germany

[3] Karolinska Inst, Ctr Family Med, Huddinge, Sweden

[4] Tech Univ Munich, Dept Obstet & Gynaecol, Klinikum Rechts Isar, D-8000 Munich, Germany

[5] Univ Cologne, Div Mol Gynaecooncol, Dept Obstet & Gynaecol, Ctr Clin, Cologne, Germany

[6] Univ Hosp Cologne, CMMC, Cologne, Germany

[7] Univ Heidelberg, Inst Human Genet, Heidelberg, Germany

[8] Univ Heidelberg, Fac Clin Med, Inst Transfus Med & Immunol, Red Cross Blood Serv Baden Wurttemberg Hessia, Mannheim, Germany

来源：

BMC CANCER | 2007年 / 7卷 / 1期

关键词：

D O I：

10.1186/1471-2407-7-83

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Inactivating and truncating mutations of the nuclear BRCA1-interacting protein 1 (BRIP1) have been shown to be the major cause of Fanconi anaemia and, due to subsequent alterations of BRCA1 function, predispose to breast cancer ( BC). Methods: We investigated the effect of BRIP1 - 64G > A and Pro919Ser on familial BC risk by means of TaqMan allelic discrimination, analysing BRCA1/BRCA2 mutation-negative index patients of 571 German BC families and 712 control individuals. Results: No significant differences in genotype frequencies between BC cases and controls for BRIP1 - 64G > A and Pro919Ser were observed. Conclusion: We found no effect of the putatively functional BRIP1 variants - 64G > A and Pro919Ser on the risk of familial BC.

引用

下载

页数：4

共 50 条

[21] Mutations in BRIP1 confer high risk of ovarian cancer
Thorunn Rafnar
Daniel F Gudbjartsson
Patrick Sulem
Aslaug Jonasdottir
Asgeir Sigurdsson
Adalbjorg Jonasdottir
Soren Besenbacher
Pär Lundin
Simon N Stacey
Julius Gudmundsson
Olafur T Magnusson
Louise le Roux
Gudbjorg Orlygsdottir
Hafdis T Helgadottir
Hrefna Johannsdottir
Arnaldur Gylfason
Laufey Tryggvadottir
Jon G Jonasson
Ana de Juan
Eugenia Ortega
Jose M Ramon-Cajal
Maria D García-Prats
Carlos Mayordomo
Angeles Panadero
Fernando Rivera
Katja K H Aben
Anne M van Altena
Leon F A G Massuger
Mervi Aavikko
Paula M Kujala
Synnöve Staff
Lauri A Aaltonen
Kristrun Olafsdottir
Johannes Bjornsson
Augustine Kong
Anna Salvarsdottir
Hafsteinn Saemundsson
Karl Olafsson
Kristrun R Benediktsdottir
Jeffrey Gulcher
Gisli Masson
Lambertus A Kiemeney
Jose I Mayordomo
Unnur Thorsteinsdottir
Kari Stefansson
Nature Genetics, 2011, 43 : 1104 - 1107
[22] Mutations in BRIP1 confer high risk of ovarian cancer
Rafnar, Thorunn
Gudbjartsson, Daniel F.
Sulem, Patrick
Jonasdottir, Aslaug
Sigurdsson, Asgeir
Jonasdottir, Adalbjorg
Besenbacher, Soren
Lundin, Par
Stacey, Simon N.
Gudmundsson, Julius
Magnusson, Olafur T.
le Roux, Louise
Orlygsdottir, Gudbjorg
Helgadottir, Hafdis T.
Johannsdottir, Hrefna
Gylfason, Arnaldur
Tryggvadottir, Laufey
Jonasson, Jon G.
de Juan, Ana
Ortega, Eugenia
Ramon-Cajal, Jose M.
Garcia-Prats, Maria D.
Mayordomo, Carlos
Panadero, Angeles
Rivera, Fernando
Aben, Katja K. H.
van Altena, Anne M.
Massuger, Leon F. A. G.
Aavikko, Mervi
Kujala, Paula M.
Staff, Synnove
Aaltonen, Lauri A.
Olafsdottir, Kristrun
Bjornsson, Johannes
Kong, Augustine
Salvarsdottir, Anna
Saemundsson, Hafsteinn
Olafsson, Karl
Benediktsdottir, Kristrun R.
Gulcher, Jeffrey
Masson, Gisli
Kiemeney, Lambertus A.
Mayordomo, Jose I.
Thorsteinsdottir, Unnur
Stefansson, Kari
NATURE GENETICS, 2011, 43 (11) : 1104 - U91
[23] Analysis of BRIP1 in italian male breast cancer patients
Silvestri, V.
Rizzolo, P.
Falchetti, M.
Zanna, I.
Palli, D.
Ottini, L.
EJC SUPPLEMENTS, 2010, 8 (05): : 24 - 24
[24] Comprehensive Mutational Analysis of the BRCA1-Associated DNA Helicase and Tumor-Suppressor FANCJ/BACH1/BRIP1
Calvo, Jennifer A.
Fritchman, Briana
Hernandez, Desiree
Persky, Nicole S.
Johannessen, Cory M.
Piccioni, Federica
Kelch, Brian A.
Cantor, Sharon B.
MOLECULAR CANCER RESEARCH, 2021, 19 (06) : 1015 - 1025
[25] Meta-Analysis of Association Between BRIP1 Polymorphisms and Breast Cancer Risk
Dianatpour, Ali
Faramarzi, Sepideh
Ghafouri-Fard, Soudeh
INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2019, 12 (01)
[26] BRIP1, a Gene Potentially Implicated in Familial Colorectal Cancer Type X
Martin-Morales, Lorena
Garre, Pilar
Lorca, Victor
Cazorla, Marta
Llovet, Patricia
Bando, Inmaculada
Garcia-Barberan, Vanesa
Luisa Gonzalez-Morales, Maria
Esteban-Jurado, Clara
de la Hoya, Miguel
Castellvi-Bel, Sergi
Caldes, Trinidad
CANCER PREVENTION RESEARCH, 2021, 14 (02) : 165 - 173
[27] Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer
Kim, Haeyoung
Cho, Dae-Yeon
Choi, Doo Ho
Jung, Gee Hue
Shin, Inkyung
Park, Won
Huh, Seung Jae
Nam, Seok Jin
Lee, Jeong Eon
Gil, Won Ho
Kim, Seok Won
CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 955 - 961
[28] FAMILIAL RISK OF BREAST-CANCER IN A FRENCH CASE-CONTROL STUDY
ANDRIEU, N
CLAVEL, F
GAIRARD, B
PIANA, L
BREMOND, A
LANSAC, J
FLAMANT, R
RENAUD, R
CANCER DETECTION AND PREVENTION, 1994, 18 (03): : 163 - 169
[29] BACH1 Ser919Pro variant and breast cancer risk
Pia Vahteristo
Kristiina Yliannala
Anitta Tamminen
Hannaleena Eerola
Carl Blomqvist
Heli Nevanlinna
BMC Cancer, 6
[30] Two tSNPs in BRIP1 are associated with breast cancer during TDT analysis
Li, Xuefei
Li, Zhuo
Yang, Miao
Luo, Yan
Hu, Li
Xiao, Zhi
Huang, Aji
Huang, Juan
MOLECULAR GENETICS & GENOMIC MEDICINE, 2021, 9 (02):

← 1 2 3 4 5 →